Neurotech International Share Price and Company Fundamentals
Last traded: Today at 4:54 AM
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company focuses on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
4.67
Dividend yield
-
Beta
0.04
Market cap
$18.15M
Enterprise value
$11.66M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://neurotechinternational.com |
| Mailing address | 55 Collins Street Suite 102 Level 1 Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9498 3130 / 61 8 9389 3199 |
Dividends
More: Neurotech International Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Neurotech International paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NTI dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Neurotech International.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Anthony Filippis M.B.A., Ph.D. | MD, CEO & Director | ||
| Mr. Gerald Quigley | Director of Public Relations & Director | ||
| Dr. Emanuela Russo | Chief Scientific Officer & Member of Scientific Advisory Board | ||
| Associate Prof. Carolyn Ellaway | Chief Medical Officer | ||
| Dr. Bonni Goldstein M.D. | Chief Medical Advisor for USA | 61 | |
| Mr. Peter James Lawrence Griffiths B.Sc. | Chief Executive Officer of AAT Research Ltd | 61 | |
| Ms. Alessandra Marie Gauvin | Company Secretary |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-141.21%
Return on assets
-86.84%
Return on equity
-142.71%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Neurotech International is 18.15M and its enterprise value is 11.66M. The enterprise value to revenue ratio of NTI is 4.77. The enterprise value to EBITDA ratio of NTI is -1.09.
The NTI's stocks Beta value is 0.04 making it 96% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Neurotech International (NTI)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Neurotech International (ASX:NTI) Frequently Asked Questions
1. What is Neurotech International's Stock Symbol?
Neurotech International trades on ASX under the ticker symbol "NTI".
2. What is Neurotech International's stock price today?
One share of NTI stock can currently be purchased for approximately $0.014.
3. How can I contact Neurotech International?
Neurotech International's mailing address is 55 Collins Street Suite 102 Level 1 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9498 3130.
4. What is Neurotech International's official website?
The official website of Neurotech International is https://neurotechinternational.com.